protein

HA (H1N1)(A/Brisbane/59/2007) (aa 18-530)

MBS434115

0.05 mg

365 USD

Recombinant Protein

HA (H1N1)(A/Brisbane/59/2007) (aa 18-530)

HA (H1N1)(A/Brisbane/59/2007)

HA (H1N1)(A/Brisbane/59/2007); glycosylated recombinant protein; HA (aa 18-530)(H1N1) (A/Brisbane/59/2007); HA (H1N1)(A/Brisbane/59/2007) (aa 18-530), glycosylated recombinant protein

HA

293 cell culture

> 95% pure by 10%(SDS-PAGE)gel

1 ug/ ul in PBS.

Store at -20 degree C. Stable for 6-months from the date of shipment when kept at 4 degree C. Non-hazardous. No MSDS required.

Western Blot (WB), ELISA (EIA), Immunogen

Viral Protein: C-terminal 6xHis tagged HA (H1N1)(A/Brisbane/59/2007) protein (amino acid 18-530) (Genebank No. ACA28846).

Viral Recombinant Proteins; Influenza

Description: 6xHis tagged Hemagglutinin (amino acid 18-530) (H1N1)(A/Brisbane/59/2007) (Genebank No. ACA28846). Viral protein purified from 293 cell culture. Introduction: Influenza hemagglutinin (HA) is a type of hemagglutinin found on the surface of the influenza viruses. HA is an antigenic glycoprotein, like all other hemagglutinins, it causes red blood cells to agglutinate. HA is responsible for binding the virus to the cell that is being infected. HA proteins bind to cells with sialic acid on the membranes, such as cells in the upper respiratory tract or erythrocytes. HA is a homotrimeric integral membrane glycoprotein. HA monomer is synthesized as a single polypeptide that is subsequently cleaved into two smaller polypeptides, the HA1 and HA2 subunits. Each HA monomer consists of a long, helical chain anchored in the membrane by HA2 and topped by a large HA1 globule.

0.05 mg

365 USD